Literature DB >> 24246981

Innate and adaptive immunity in inflammatory bowel diseases.

Sebastian Foersch1, Maximilian J Waldner, Markus F Neurath.   

Abstract

While barrier function and the effects of the intestinal microbiome have only recently moved into the focus of inflammatory bowel disease research, the role of the innate and the adaptive immune system in these gastrointestinal disorders has extensively been studied. Although still not completely understood, the increasing knowledge about the immune system's contribution to the pathophysiology of inflammatory bowel diseases has led to new diagnostic and therapeutic approaches. This review gives a compact overview on this important topic.

Entities:  

Mesh:

Year:  2013        PMID: 24246981     DOI: 10.1159/000354685

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  5 in total

1.  Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy?

Authors:  Luca Vergano; Elisa Loiacono; Roberto Albera; Rosanna Coppo; Roberta Camilla; Licia Peruzzi; Alessandro Amore; Maria Elena Donadio; Federica Chiale; Alberto Boido; Filippo Mariano; Gianna Mazzucco; Sara Ravera; Giovanni Cancarini; Riccardo Magistroni; Giulietta Beltrame; Cristiana Rollino; Piero Stratta; Marco Quaglia; Roberto Bergia; Raffaella Cravero; Stefano Cusinato; Luisa Benozzi; Silvana Savoldi; Carola Licata
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

2.  Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.

Authors:  Nicholas Horton; Xianrui Wu; Jessica Philpott; Ari Garber; Jean-Paul Achkar; Aaron Brzezinski; Bret A Lashner; Bo Shen
Journal:  Dig Dis Sci       Date:  2016-09-12       Impact factor: 3.199

3.  Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn's Disease and Ulcerative Colitis.

Authors:  Maria E C Bruno; Eric W Rogier; Razvan I Arsenescu; Deborah R Flomenhoft; Cathryn J Kurkjian; Gavin I Ellis; Charlotte S Kaetzel
Journal:  Dig Dis Sci       Date:  2015-05-09       Impact factor: 3.199

Review 4.  Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease.

Authors:  Yaron Ilan
Journal:  Clin Transl Immunology       Date:  2016-01-29

5.  Adaptive Returns of Deficient Systemic Plasma Immunoglobulin G Levels as Rehabilitation Biomarker After Emergency Colectomy for Fulminant Ulcerative Colitis.

Authors:  Alexander T Hawkins; Jun W Um; Amosy E M'Koma
Journal:  Clin Med Insights Gastroenterol       Date:  2017-12-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.